Learn About Paget Disease of the Breast

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Paget Disease of the Breast Local Doctors?
Learn about our expert tiers
Learn more
What are the Latest Advances for Paget Disease of the Breast?
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
Tired of the same old research?
Check Latest Advances
Adenoma of the nipple: a mimic of breast malignancy.
What are the latest Paget Disease of the Breast Clinical Trials?
A Phase II Study of Talimogene Laherparepvec Followed by Talimogene Laherparepvec + Nivolumab in Refractory T Cell and NK Cell Lymphomas, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, and Other Rare Skin Tumors

Summary: This phase II trial studies how well talimogene laherparepvec and nivolumab work in treating patients with lymphomas that do not responded to treatment (refractory) or non-melanoma skin cancers that have spread to other places in the body (advanced) or do not responded to treatment. Biological therapies, such as talimogene laherparepvec, use substances made from living organisms that may stimulate...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prospective Registry of Gynecologic Patients With Extramammary Paget's Disease

Summary: In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.